Skinvisible (SKVI) Asset Utilization Ratio (2011 - 2026)
Skinvisible's (SKVI) quarterly Asset Utilization Ratio came in at 0.16 in Q2 2026, up 20.67% year-over-year from 0.14 in Q2 2025, and up 1.74% quarter-over-quarter from 0.16 in Q1 2026.
Analysis
Skinvisible (SKVI) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Skinvisible has disclosed Asset Utilization Ratio across 16 years of filings, most recently posting 0.16 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio rose 20.67% year-over-year to 0.16; the TTM figure through Jun 2026 stood at 0.16 (up 20.67% YoY), while the FY2025 annual figure was 0.14, up 12.35% from the prior year.
- Asset Utilization Ratio came in at 0.16 for Q2 2026 at Skinvisible, up from 0.16 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 3.46 in Q1 2022 to a low of 0.1 in Q3 2023.
- Average Asset Utilization Ratio over 5 years is 0.64, with a median of 0.14 recorded in 2025.
- Year-over-year, Asset Utilization Ratio soared 306.79% in 2022 and slumped 95.16% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 1.06 in 2022, then sank by 89.18% to 0.11 in 2023, then gained by 13.38% to 0.13 in 2024, then increased by 17.49% to 0.15 in 2025, then climbed by 7.59% to 0.16 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.16 in Q2 2026, 0.16 in Q1 2026, and 0.15 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.02 Bn | 629.26 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 443.38 Bn | 436.81 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 368.22 Bn | 361.07 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 270.16 Bn | 262.47 Bn | 11.24 Bn | 0.57 |
| 5 | Pfizer | 158.63 Bn | 146.93 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 52.92 Bn | 45.54 Bn | 10.79 Bn | 0.36 |
| 7 | Revolution Medicines | 44.49 Bn | 44.49 Bn | - | - |
| 8 | Incyte | 25.22 Bn | 20.69 Bn | 1.57 Bn | 0.77 |
| 9 | United Therapeutics | 21.17 Bn | 18.51 Bn | 683.80 Mn | 0.45 |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 0.16 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.16 |
| Mar 31, 2026 | 0.16 |
| Dec 31, 2025 | 0.15 |
| Sep 30, 2025 | 0.14 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.13 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.13 |
| Jun 30, 2024 | 0.13 |
| Mar 31, 2024 | 0.13 |
| Dec 31, 2023 | 0.11 |
| Sep 30, 2023 | 0.10 |
| Jun 30, 2023 | 0.12 |
| Mar 31, 2023 | 0.99 |
| Dec 31, 2022 | 1.06 |
| Sep 30, 2022 | 1.76 |
| Jun 30, 2022 | 2.50 |
| Mar 31, 2022 | 3.46 |
| Dec 31, 2021 | 2.99 |
| Sep 30, 2021 | 1.98 |